Search Count: 22
 |
Human Jak3 Kinase Domain With 1-(4-((2-((1-Methyl-1H-Pyrazol-4-Yl)Amino)Quinazolin-8-Yl)Amino)Piperidin-1-Yl)Ethan-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 934, SO4, PHU |
 |
Jak2 In Complex With 4-{8-Methoxy-2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]Quinazolin-6-Yl}Phenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I8 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I5 |
 |
Jak2 In Complex With 4-(2-Amino-8-{[(2S)-1-Hydroxypropan-2-Yl]Amino}Quinazolin-6-Yl)-5-Ethyl-2-Fluorophenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9I2, GOL |
 |
Jak2 In Complex With 4-(2-{[5-(Dimethylamino)Pentyl]Amino}-8-{[(2S)-1-Hydroxypropan-2-Yl]Amino}Quinazolin-6-Yl)-5-Ethyl-2-Fluorophenol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-02-02 Classification: SIGNALING PROTEIN Ligands: 9HR |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
 |
C-Terminal Bromodomain Of Human Brd4 N-(2,2-Diphenylethyl)-4-Methoxy-3,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: V9Z |
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, NV2 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-(2,2-Diphenylethyl)-1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: VBH, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-N-(2-Phenylpropyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, VBE |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-2-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-6-(1-Phenylethyl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-04-07 Classification: NUCLEAR PROTEIN Ligands: UME, EDO, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 3-(2-(Benzyloxy)Phenyl)-5-Methyl-1H-1,2,4-Triazole
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULB |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(1-Phenylethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UL8 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(Pyridin-2-Ylmethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UM5 |
 |
C-Terminal Bromodomain Of Human Brd2 With 2-Benzyl-N-Cyclopropyl-6-(1-Methyl-1H-1,2,3-Triazol-4-Yl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: UMB, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 2-Benzyl-N-Cyclopropyl-6-(1-Methyl-1H-1,2,3-Triazol-4-Yl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: UM8, EDO |